Clinical trial
An Observational Multicenter Study to Evaluate the Safety and Efficacy of Humacyte's Human Acellular Vessel in a Real World Setting for Arterial Replacement or Reconstruction in Ukrainian Patients With Life or Limb-threatening Vascular Trauma
NCT05873959 is registered in ClinicalTrials.gov with Humacyte, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- An Observational Multicenter Study to Evaluate the Safety and Efficacy of Humacyte's Human Acellular Vessel in a Real World Setting for Arterial Replacement or Reconstruction in Ukrainian Patients With Life or Limb-threatening Vascular Trauma
- Lead sponsor
- Humacyte, Inc.
- Phase
- Observational
- Overall status
- Completed
- Start date
- May 1, 2023
- Completion date
- January 15, 2024
- Enrollment
- 17 (actual)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.
trauma, trauma blunt, trauma injury, trauma, multiple